Cognos Therapeutics is a medical technology company focused on developing unique, radically advanced devices for the treatment of neurological diseases including brain and spinal cancers, and ...

For a long time now, users have been asking what Big Blue plans on doing with all the acquisitions in business intelligence and analytics space (news, site) it made. The release of Cognos 10, which ...

In the past two years, if we look at the changes that took place in the technology panorama, it is observed that Business Intelligence Reporting tools are contributing a great part in the businesses ...

IBM recently announced new business analytics offerings designed to help clients better manage and control their unstructured and structured data in a unified manner, while providing valuable insight ...

Making informed business decisions is made easier with Cognos’ intelligent interactive dashboards. A machine learning system and artificial intelligence technology are built into its system, ...

In a move rumored for months, Big Blue to pay $5 billion in cash for the business intelligence company to fill out its information management portfolio. Martin LaMonica is a senior writer covering ...

BOSTON — IBM Corp. is making its largest acquisition ever, a deal announced Monday to buy Cognos Inc. for $5 billion in cash in hopes of keeping up with rivals in “business intelligence” software. The ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...